2-piperidone has been researched along with chitosan in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Carvalho, VFM; Chorilli, M; Costa-Fernandez, S; Costa-Lotufo, LV; de Araujo, GLB; de Matos, JKR; Lopes, LB; Salata, GC; Silveira, ER; Steiner, AA | 1 |
Costa-Lotufo, LV; Dartora, VFMC; de Matos, JKR; de Oliveira, EA; Giacone, DV; Lopes, LB; Maria-Engler, SS; Miranda, DAG; Passos, JS; Silveira, ER | 1 |
Branco, PC; Costa-Lotufo, LV; Dartora, VFC; Lopes, LB; Passos, JS; Salata, GC; Silveira, E; Steiner, AA | 1 |
3 other study(ies) available for 2-piperidone and chitosan
Article | Year |
---|---|
Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting.
Topics: Adhesiveness; Animals; Antineoplastic Agents, Phytogenic; Chickens; Chitosan; Chorioallantoic Membrane; Dioxolanes; Drug Administration Routes; Emulsions; Female; Glycerol; Hyaluronic Acid; Mammary Glands, Animal; Nanoparticles; Phosphatidylcholines; Piperidones; Polysorbates; Rats, Wistar; Skin; Swine | 2019 |
Effect of nanoemulsion modification with chitosan and sodium alginate on the topical delivery and efficacy of the cytotoxic agent piplartine in 2D and 3D skin cancer models.
Topics: Alginates; Cell Proliferation; Chitosan; Cytotoxins; Emulsions; Humans; Melanocytes; Melanoma; Nanoparticles; Piperidones; Skin Neoplasms | 2020 |
Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration.
Topics: Breast Neoplasms; Chitosan; Female; Humans; Hyaluronic Acid; Nanoparticles; Piperidones | 2022 |